These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation. Garnero C; Zoppi A; Genovese D; Longhi M Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225 [TBL] [Abstract][Full Text] [Related]
3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related]
5. Solid state characterization of progesterone in a freeze dried 1:2 progesterone/HPBCD mixture. Zoppetti G; Puppini N; Ospitali F; Fini A J Pharm Sci; 2007 Jul; 96(7):1729-36. PubMed ID: 17514727 [TBL] [Abstract][Full Text] [Related]
6. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. Jug M; Maestrelli F; Bragagni M; Mura P J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541 [TBL] [Abstract][Full Text] [Related]
7. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A. Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811 [TBL] [Abstract][Full Text] [Related]
8. Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination. Garnero C; Longhi M J Pharm Biomed Anal; 2007 Nov; 45(4):536-45. PubMed ID: 17851014 [TBL] [Abstract][Full Text] [Related]
9. ATR/Raman and fractal characterization of HPBCD/progesterone complex solid particles. Fini A; Ospitali F; Zoppetti G; Puppini N Pharm Res; 2008 Sep; 25(9):2030-40. PubMed ID: 18597163 [TBL] [Abstract][Full Text] [Related]
10. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin. Guo B; Zhong S; Li N; Li X; Yi J; Jin M Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with β-cyclodextrin. Ozdemir N; Erkin J Drug Dev Ind Pharm; 2012 Mar; 38(3):331-40. PubMed ID: 22059382 [TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin. Liu J; Qiu L; Gao J; Jin Y Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034 [TBL] [Abstract][Full Text] [Related]
14. Improvement on solubility of fluticasone propionate with cyclodextrins by mechanochemical activation. Dai J; Liang X; Su W Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):799-806. PubMed ID: 25796157 [TBL] [Abstract][Full Text] [Related]
15. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena. Sinha VR; Nanda A; Chadha R; Goel H Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941 [TBL] [Abstract][Full Text] [Related]
16. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex. Jadhav GS; Vavia PR Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545 [TBL] [Abstract][Full Text] [Related]
17. Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration. Nekkanti V; Karatgi P; Paruchuri S; Pillai R Drug Deliv; 2011 May; 18(4):294-303. PubMed ID: 21214430 [TBL] [Abstract][Full Text] [Related]
18. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin. Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924 [TBL] [Abstract][Full Text] [Related]
19. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling. Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001 [TBL] [Abstract][Full Text] [Related]
20. Alpinetin/hydroxypropyl-β-cyclodextrin host-guest system: preparation, characterization, inclusion mode, solubilization and stability. Ma SX; Chen W; Yang XD; Zhang N; Wang SJ; Liu L; Yang LJ J Pharm Biomed Anal; 2012; 67-68():193-200. PubMed ID: 22633603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]